Bacterial Conjunctivitis Treatment Guidelines

Introduction to Treatment

For patients with bacterial conjunctivitis who are unable to use eye drops or ointments, systemic oral antibiotics are the definitive alternative, with the specific agent determined by the suspected or confirmed pathogen, as recommended by the American Academy of Ophthalmology 1, 2

For suspected chlamydial conjunctivitis, the first-line treatment is Azithromycin 1 g orally as a single dose, according to the Centers for Disease Control and Prevention 1, 2
For suspected gonococcal conjunctivitis in adults, the recommended treatment is Ceftriaxone 250 mg intramuscular single dose PLUS Azithromycin 1 g orally single dose, as suggested by the American Academy of Ophthalmology 1, 2
For children weighing ≤45 kg with suspected gonococcal conjunctivitis, the treatment is Ceftriaxone 25-50 mg/kg IV or IM single dose, according to the American Academy of Pediatrics 1

Gonococcal conjunctivitis requires systemic therapy, as topical treatment alone is insufficient, and the American Academy of Ophthalmology recommends immediate treatment to prevent vision loss and corneal perforation 2
Chlamydial conjunctivitis also requires systemic therapy, as it causes intracellular infection requiring systemic penetration, and the Centers for Disease Control and Prevention recommend treatment to prevent long-term complications 2

Neonates with gonococcal ophthalmia neonatorum should be treated with Ceftriaxone 25-50 mg/kg IV or IM single dose, as recommended by the American Academy of Pediatrics 1
Children ≥8 years with chlamydial infection can be treated with Azithromycin 1 g orally single dose OR Doxycycline 100 mg orally twice daily for 7 days, according to the Centers for Disease Control and Prevention 1

Delayed treatment of gonococcal conjunctivitis can lead to poor outcomes, including vision loss and corneal perforation, and the American Academy of Ophthalmology recommends prompt treatment 2
It is essential to screen for concurrent genital infections and treat sexual partners in cases of chlamydial and gonococcal conjunctivitis, as recommended by the Centers for Disease Control and Prevention 2